PAREXEL Receives Consecutive Recognitions from Forbes and FlexJobs for its Workplace Culture
PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced that the Company has once again been recognized for its diverse and flexible workplace by Forbes and FlexJobs.
For the second consecutive year PAREXEL was named to Forbes’ “America’s Best Employers for Diversity,” ranking highest among clinical research organizations (CROs) included. The ranking is based on results of independent survey responses from more than 50,000 Americans working for companies from various markets including healthcare, technology and more, and also factors in executive diversity and proactive diversity and inclusion initiatives.
PAREXEL was also recognized by FlexJobs as a “Top 100 Companies with Remote Jobs in 2019,” for the sixth consecutive year. The ranking recognizes companies that provide the most remote-friendly positions. PAREXEL offers its more than 20,000 global employees flexible work options, including telecommuting, flexible schedules, and home-based employment. In North America, 54 percent of PAREXEL’s employees take advantage of the Company’s telecommuting and flexible work opportunities.
“Our employees’ extensive expertise, passion and dedication are at the core of what makes us a leader in the CRO and biopharmaceutical services sector. We are honored to be recognized by Forbes and FlexJobs for creating a collaborative, inclusive environment that allows employees to thrive as individuals in their mission to help our clients prevent and cure disease,” said Michele Fournier, Senior Vice President and Chief Human Resources Officer, PAREXEL. “What unites our diverse team of professionals is our focus on one goal: getting treatments into the hands of those who need them most.”
To learn more about career opportunities at PAREXEL, please visit https://Jobs.PAREXEL.com/.
About PAREXEL International
PAREXEL International Corporation is a leading innovator of global biopharmaceutical services. We simplify our clients’ journey of transforming scientific discoveries into new medical treatments for patients with high-quality Phase I-IV clinical research, regulatory, consulting and market access services. PAREXEL develops breakthrough innovations and solutions by leveraging its comprehensive therapeutic, technical and functional expertise, in more than 100 countries around the world. For more information, visit our website and follow us on LinkedIn and Twitter.
PAREXEL is a registered trademark of PAREXEL International Corporation. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190128005040/en/